Zarejestruj się, aby utworzyć powiadomienia dla instrumentów,
wydarzeń ekonomicznych i analiz obserwowanych autorów
Darmowa rejestracja Posiadasz już konto? Logowanie
Notowania
Wszystkie aktywa
- Wszystkie aktywa
- Indeksy
- Akcje
- ETF
- Fundusze
- Towary
- Waluty
- Krypto
- Obligacje
- Certyfikaty
Prosimy o wyszukanie innej nazwy
🐦 Promocja dla najszybszych! Zgarnij najgorętsze akcje za grosze. Teraz InvestingPro 55% TANIEJ. Łap okazje na Czarny Piątek
AKTYWUJ RABAT
Blackrock Global Funds - World Healthscience Fund I2 (0P0001H44J)
Dodaj/usuń z portfela
Dodaj do listy obserwowanych
16,290
+0,240
+1,50%
22/11 - Zamknięty. Wartość w USD
Typ:
Fundusz
Rynek:
Luksemburg
Emitent:
BlackRock (Luxembourg) SA
ISIN:
LU1960219225
Klasa aktywu:
Akcja
- Ocena firmy Morningstar:
- Aktywa ogółem: 1,47B
BlackRock Global Funds - World Healthscience Fund
16,290
+0,240
+1,50%
- Przegląd
- Wykres
- Wiadomości i analizy
- Techniczna
- Forum
- Przegląd
- Profil
- Dane historyczne
- Aktywa
Przegląd 0P0001H44J
Na tej stronie znajdziesz szczegółowy profil Blackrock Global Funds - World Healthscience Fund I2. Uzyskaj informacje m.in. o kluczowych członkach kierownictwa, sumie aktywów, strategii inwestycyjnej i danych kontaktowych 0P0001H44J.
Informacje kontaktowe
Adres
35 A, avenue J.F. Kennedy,
Luxembourg, L-1855
Luxembourg
Luxembourg, L-1855
Luxembourg
Telefon
+44 20 77433000
Fax
Amsterdam
Internet
www.blackrock.com
Kierownictwo najwyższego szczebla
| Nazwa | Tytuł | Od | Do |
|---|---|---|---|
| Xiang Liu | Director | 2020 | Teraz |
| Biografia | Xiang Liu, PhD, Director, is a member of the Health Sciences team, part of BlackRock’s Active Equity Group. He is co-portfolio manager for the Health Sciences equity portfolios and is responsible for coverage of the medical devices & supplies sector. Prior to joining BlackRock in 2008, Mr. Liu was a partner and biotech analyst at Mehta Partners. From 2002 to 2005, he was a Director in the corporate development department at Cubist Pharmaceuticals. Mr. Liu began his investment career in 2000 at the Boston Consulting Group as a Healthcare consultant. Mr. Liu earned a BS degree in Chemistry from the University of Science & Technology, China in 1993, a PhD degree in Chemistry from Yale University in 1997, and a MBA degree in finance, strategy, and accounting from the University of Chicago in 2000. | ||
| Erin Xie | Managing Director | 2011 | Teraz |
| Biografia | Erin Xie, PhD, Managing Director and portfolio manager, is the head of the Health Sciences team, part of BlackRock’s Active Equity Group. She is the lead portfolio manager for the Health Sciences equity portfolios. Ms. Xie's service with the firm dates back to 2001, including her years with State Street Research & Management (SSRM), which merged with BlackRock in 2005. At SSRM, she was a Senior Vice President and portfolio manager responsible for managing the State Street Health Sciences Fund. Prior to joining State Street Research in 2001, Ms. Xie was a research associate with Sanford Bernstein covering the pharmaceutical industry from 1999. From 1994 until 1997, she was a post doctoral research scientist at Columbia University. Ms. Xie earned a BS degree in chemistry from Beijing University in 1988, a PhD degree in Biochemistry from the University of California, Los Angeles, in 1993 and a MBA degree from the Massachusetts Institute of Technology Sloan School of Management in 1999. | ||
| Jeff Lee | - | 2020 | 2023 |
| Biografia | Jeffrey Lee, Director, is a member of the Health Sciences team, part of BlackRock’s Active Equity Group. He is co-portfolio manager for the Health Sciences equity portfolios and is responsible for coverage of the healthcare providers and services sector. Prior to joining BlackRock in 2011, Mr. Lee was a member of the healthcare investment team at Duquesne Capital Management where he covered provider and service companies. From 2006 to 2008, Mr. Lee was an healthcare private equity associate at Altaris Capital Partners where he sourced and analyzed equity transactions for public and private healthcare companies. Prior to 2006, Mr. Lee was an analyst at Citigroup within the healthcare finance and investment banking group where he valued and helped structured financing for managed care providers, hospital companies and other large healthcare systems. Mr. Lee earned a BA degree in economics, cum laude, from Princeton University in 2004. | ||
| Thomas P. Callan | Managing Director | 2011 | 2017 |
| Biografia | Thomas P. Callan, CFA, Managing Director and senior portfolio manager, is head of BlackRock's Global Opportunities equity team. He oversees the team's investment process, leads the team's Investment Strategy Group, and provides portfolio and risk management oversight for all of the team's products. In addition, Mr. Callan is a member of BlackRock's Leadership Committee. Mr. Callan's service with the firm dates back to 1988, including his years with PNC Asset Management Group, which was integrated with BlackRock in 1998. He started as a health care analyst for PNC's mutual fund group and later served as an international equity analyst. Mr. Callan began his investment career at PNC Bank as a personal trust portfolio manager in 1988. Mr. Callan earned a BA degree in economics, with honors, from Boston College in 1981. | ||
| Bob Hodgson | - | 2005 | 2011 |
Napisz co myślisz o Blackrock Global Funds - World Healthscience Fund I2
Czy na pewno chcesz usunąć ten wykres?
Usuń Anuluj
Zastąpić dołączony wykres nowym wykresem?
Zastąp Anuluj
Wytyczne do komentarzy
Dodaj wykres do komentarza
Potwierdź zablokowanie
Czy na pewno chcesz zablokować %USER_NAME%?
Po włączeniu opcji blokady, ani Ty ani %USER_NAME% nie będziecie mogli zobaczyć swoich postów na Investing.com.
%USER_NAME% został pomyślnie dodany do Twojej Listy zablokowanych
Ponieważ właśnie odblokowałeś tę osobę, aby móc ponownie ją zablokować musi minąć 48 godzin.
Zgłoś ten komentarz
Uważam, że ten komentarz jest:
Komentarz zgłoszony
Dziękujemy!
Twoje zgłoszenie zostało wysłane do naszych moderatorów w celu rewizji